indicate statistically significant differences. Binding of a specific protein to the CA-rich sequence Next, we used EMSA to determine whether protein(s) from Leydig cell nuclear extracts could specifically bind to the CA-rich sequence in the
Search Results
Maxime A Tremblay, Raifish E Mendoza-Villarroel, Nicholas M Robert, Francis Bergeron, and Jacques J Tremblay
Silvia Ottaviani, Greg N Brooke, Ciara O'Hanlon-Brown, Jonathan Waxman, Simak Ali, and Laki Buluwela
placed in boiling water, which was allowed to cool at room temperature overnight. For electrophoretic mobility shift assay (EMSA), 2.5 μl COS-1 HSB extract were pre-incubated with 142 ng/μl poly(deoxyinosine-deoxycytosine) (dI.dC) for 30 min at 4 °C. For
Robin L Thomas, Natalie M Crawford, Constance M Grafer, Weiming Zheng, and Lisa M Halvorson
oligonucleotides Sequences (mutated residues underlined) EMSA WT (−209/−167) 5′-ATGCTGACGTCTTTTACTGATACCGGATCATTACGTGACTGGG-3′ Mutant −191 GATA 5′-ATGCTGACGTCTTTTACTG CC ACCGGATCATTACGTGACTGGG-3′ Mutant −205 CRE 5′-ATGCTG TG GTCTTTTACTGATACCGGATCATTACGTGACTGGG
Karine Steketee, Angelique C J Ziel-van der Made, Hetty A G M van der Korput, Adriaan B Houtsmuller, and Jan Trapman
mobility shift assay (EMSA) probes were used: PSA ARE I: 5′-GATCCTTGCAGAA CAGCAAGTGCTAGCTG-3′; 3′-GAACGTCT TGTCGTTCACGATCGACCTAG-5′; Probasin ARE II: 5′-TCGACTAGGTTCTTGGAGTACT TTG-3′; 3′-GATCCAAGAACCTCATGAAACA GCT-5′; ARE-SARG+4.6: 5′-TCGACACTGTG
Ralph A Zirngibl, Janet S M Chan, and Jane E Aubin
II (Invitrogen), real-time PCR was performed (Bio-Rad MyiQ cycler) and relative expression levels of rOPN were determined using rL32 as internal control. Electrophoretic mobility shift assay (EMSA) EMSA was performed essentially as described ( Ausubel
M J Moreno-Aliaga, M M Swarbrick, S Lorente-Cebrián, K L Stanhope, P J Havel, and J A Martínez
electrophoretic mobility shift assays (EMSAs) to test the hypothesis that the transcription factor Sp1 mediates the stimulatory effects of insulin-mediated glucose metabolism. Finally, we incubated primary adipocyte cultures with a specific inhibitor of Sp1
Yunguang Tong and Tamar Eigler
-Myc promoter and identified a PTTG1 DNA-binding domain (aa 61–118) using electromobility shift assay (EMSA; Pei 2001 ). Further studies suggested that PTTG1 directly binds to the c-Myc promoter at sequences −3 and −5 and between −15 and −20 (relative to
Viswanath Ragupathy, Wang Xue, Ji Tan, Krishnakumar Devadas, Yamei Gao, and Indira Hewlett
indicated earlier. Nuclear protein was extracted from whole cells using NE-PER nuclear and cytoplasmic extraction reagents (Pierce). EMSA was performed using a LightShift Chemiluminescent EMSA kit (Pierce). In EMSA, we used previously published ( Yin et al
Leandro Nieto, Mariana Fuertes, Josefina Rosmino, Sergio Senin, and Eduardo Arzt
10 min at 4°C, the microextracts were stored at −80°C. EMSA EMSA was performed as previously described ( Giacomini et al. 2009 ). Oligonucleotides were synthesized as single strand and the annealing of the complementary strands was allowed
Magda A Meester-Smoor, Anco C Molijn, Yixian Zhao, Nicole A Groen, Cora A H Groffen, Merel Boogaard, Diny van Dalsum-Verbiest, Gerard C Grosveld, and Ellen C Zwarthoff
). In 3T3 Gene-Switch cell lines expression of HA-tagged-MN1 and HA-tag (as control) were induced overnight with mifepristone (10 − 8 M) and used to generate cell lysates for electrophoretic mobility shift assays (EMSAs). Transient transfections were